| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 19 |
| 1 | DEXAMETHASONE 1.5 MG | 19 |
| 2 | METHOTREXATE SODIUM | 18 |
| 3 | METHOTREXATE | 17 |
| 4 | CYCLOPHOSPHAMIDE | 16 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 16 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 16 |
| 7 | CYTARABINE | 14 |
| 8 | MERCAPTOPURINE | 14 |
| 9 | NELARABINE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 14 | 0.0144 |
| 1 | EDARAVONE | 2 | 0.0012 |
| 2 | PEGASPARGASE | 14 | 0.0011 |
| 3 | CISATRACURIUM BESYLATE | 2 | 0.0009 |
| 4 | MERCAPTOPURINE | 14 | 0.0008 |
| 5 | WHITE PETROLATUM | 1 | 0.0007 |
| 6 | LEVALBUTEROL HYDROCHLORIDE | 2 | 0.0005 |
| 7 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 8 | REMIFENTANIL HYDROCHLORIDE | 1 | 0.0004 |
| 9 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 25 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 2 | Alkylating Drug [EPC] | 16 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 4 | Asparagine-specific Enzyme [EPC] | 14 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 8 |
| 6 | Aldosterone Antagonist [EPC] | 6 |
| 7 | Endothelin Receptor Antagonist [EPC] | 6 |
| 8 | Loop Diuretic [EPC] | 6 |
| 9 | Azole Antifungal [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 14 | 0.0010 |
| 1 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 3 | General Anesthetic [EPC] | 3 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 8 | 0.0001 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 16 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 9 | Hemoglobin S Polymerization Inhibitor [EPC] | 1 | 0.0000 |